Special clinical interest in Stereotactic Ablative Body Radiotherapy (SABR), breast and lung cancers.
Trained in oncology at the Royal Marsden Hospital and Mount Vernon Hospital in London, moving to Bristol in 2010. Dr Comins has expertise in the oncological treatment of breast and lung cancer including drug treatments and radiotherapy. Dr Comins has a special clinical interest in Stereotactic Ablative Body Radiotherapy (SABR), breast and lung cancers.
NHS Hospital / current post(s)
Consultant Clinical Oncologist, University Hospitals Bristol NHS Foundation Trust
Clinical interests
Stereotactic Ablative Body Radiotherapy (SABR), breast and lung cancers.
Professional memberships
Fellow of Royal College of Radiologists (FRCR).